alln-177
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02289755)
Timeline
Indications
Mechanism of action
- OXDCSupplementation
OXDC supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- alln-177
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03391804 | Phase 2 | Jul 17, 2018 | Allena Pharmaceuticals |
| NCT03456830 | Phase 3 | May 21, 2018 | Allena Pharmaceuticals |
| NCT02547805 | Phase 2 | Sep 1, 2015 | Allena Pharmaceuticals |
| NCT02503345 | Phase 2 | Jul 1, 2015 | Allena Pharmaceuticals |
| NCT02289755 | Phase 2 | Sep 1, 2014 | Allena Pharmaceuticals |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Allena Pharmaceuticals | For profit | 5 | 5 | 2 | 2014 |
1 organizations
Page 1 / 1